GetTopicDetailResponse(id=2dd211631807, topicName=NTRK融合陽性腫瘤, introduction=, content=NCCN指南 瑞普替尼 NTRK融合陽性腫瘤, image=null, comments=0, allHits=801, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Jul 06 23:29:13 CST 2024, time=2024-07-06, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=492781, tagList=[TagDto(tagId=492781, tagName=NTRK融合陽性腫瘤)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2213626, encodeId=a38a2213626fe, content=<a href='/topic/show?id=5406125e9c5' target=_blank style='color:#2F92EE;'>#NCCN指南#</a> <a href='/topic/show?id=61f511631e9c' target=_blank style='color:#2F92EE;'>#瑞普替尼#</a> <a href='/topic/show?id=2dd211631807' target=_blank style='color:#2F92EE;'>#NTRK融合陽性腫瘤#</a>, objectTitle=指南更新 | 多部實體瘤NCCN指南新增瑞普替尼推薦！（乳腺癌、結腸癌、直腸癌、膽道癌、肝細胞癌……）, objectType=article, longId=827172, objectId=68dc82e1729c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240704/1720065942209_92910.png, objectUrl=/article/show_article.do?id=68dc82e1729c, replyNumber=0, likeNumber=111, createdTime=2024-07-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=68dc82e1729c, moduleTitle=指南更新 | 多部實體瘤NCCN指南新增瑞普替尼推薦！（乳腺癌、結腸癌、直腸癌、膽道癌、肝細胞癌……）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=68dc82e1729c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-07-06發(fā)表于上海
